Cita APA

Crismale, J. F., Martel-Laferrière, V., Bichoupan, K., Schonfeld, E., Pappas, A., Wyatt, C., . . . Branch, A. D. (2013). Diabetes Mellitus and Advanced Liver Fibrosis Are Risk Factors for Severe Anemia During Telaprevir-based Triple Therapy.

Citación estilo Chicago

Crismale, James F., et al. Diabetes Mellitus and Advanced Liver Fibrosis Are Risk Factors for Severe Anemia During Telaprevir-based Triple Therapy. 2013.

Cita MLA

Crismale, James F., et al. Diabetes Mellitus and Advanced Liver Fibrosis Are Risk Factors for Severe Anemia During Telaprevir-based Triple Therapy. 2013.